A Deep Learning Framework for Prediction of Clinical Drug Response of Cancer Patients and Identification of Drug Sensitivity Biomarkers using Preclinical Samples
David Earl Hostallero, Lixuan Wei, Liewei Wang, Junmei Cairns, Amin Emad
This paper develops a deep learning framework called TINDL to predict cancer patient drug response and identify drug sensitivity biomarkers using preclinical samples, showing improved performance over other models.
bioRxiv · Jul 6, 2021 · PreprintBioinformatics